The aim of this study was to investigate whether environmental endocrine-disrupting chemicals, bisphenol A (BPA) and BPA-related chemicals, affect adiponectin production and secretion in 3T3-L1 adipocytes and whether BPA acts through Akt signaling. 
Introduction
Bisphenol A (BPA) is an endocrine-disrupting chemical with estrogenic actions, such as uterotrophic effects in immature rats 1) and the promotion of cell proliferation in a human estrogen-sensitive breast cancer cell line, MCF-7 2) . This chemical is used commercially in products containing polycarbonate plastics, such as baby bottles, food and water containers, linings of food and beverage cans, and dental fillings 3, 4) .
The amount of BPA liberated from new baby bottles is very small, while microgram amounts of BPA are liberated when subjected to simulated use by dishwashing, boiling, and brushing 3) . Similarly, microgram amounts of BPA are found in the liquid of preserved food in cans 5) and in the saliva of dental patients treated with fissure sealants 6) . A small amount of BPA is found in tap and lake waters 7, 8) , human serum 4, 8, 9) , and human breast milk 4) . Thus, BPA is present ubiquitously in the environment and routinely ingested by humans. Hence, there is increasing concern about the negative impact of BPA on human public health.
Obesity is one of the greatest concerns in public health because it is associated with serious morbidities, including diabetes, hyperlipidemia, hypertension, cardiovascular disease, and osteoarthritis. Obesity is the result of an increase in body adipose tissue mass pro-duced by either an enlargement of adipocytes or an increased number of adipocytes or both. Several lines of evidence reveal that endocrine-disrupting chemicals, including BPA, 4-nonylphenol, and tributyltin are associated with the induction of obesity [9] [10] [11] [12] [13] [14] [15] [16] . Takeuchi et al. 9) reported that serum BPA concentrations are higher in young obese women than in young non-obese women. We showed that exposure of mice to BPA during the perinatal and postnatal periods increased adipose tissue mass and serum cholesterol and triacylglycerol (TG) levels 15) . In cultures, BPA induced the differentiation of 3T3-L1 cells into adipocytes 12) and stimulated TG accumulation in cells through the phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway 13) . Adipose tissue is not merely an energy-storing organ but produces and secretes a variety of metabolically active proteins, including adiponectin [17] [18] [19] [20] , resistin 21) , and leptin 22) into the circulation. Adiponectin increases insulin sensitivity and protects vascular walls from atherosclerosis; hence, low plasma adiponectin levels in obesity might contribute to insulin resistance, diabetes, and atherosclerosis [18] [19] [20] . Several factors, including insulin 23) , thiazolidinediones (TZDs) 24, 25) and metformin 24) , regulate adiponectin production and secretion. Insulin increases adiponectin secretion but decreases intracellular adiponectin in 3T3-L1 adipocytes 23) . TZDs and metformin are used in the treatment of type 2 diabetes; however, both agents exert opposing effects on adiponectin expression and secretion in 3T3-L1 adipocytes. A TZD troglitazone increases adiponectin mRNA and protein expression as well as secretion, whereas metformin does not affect transcription but decreases adiponectin protein expression and secretion 24) . The aim of this study was to investigate whether BPA affects adiponectin production and secretion in cultures of 3T3-L1 adipocytes. Using Western blot analysis, we explored whether BPA regulates the expression and phosphorylation of Akt, which functions downstream of PI3K 26) , because the PI3K signaling pathway is associated with adiponectin production and secretion 23) . In addition, we examined the effects of synthetic bisphenols with different substituents at either the central carbon atom or the hydroxyl groups of the phenolic rings on adiponectin production and secretion. 
Materials and Methods

Materials
Cell Culture
3T3-L1 cells were grown to confluence in standard medium, which contained 10% (v/v) fetal bovine serum (FBS), 100 units/mL penicillin, and 100 g/mL streptomycin in Dulbecco's modified Eagle's medium (DMEM), on a 60-mm plate. One day after confluence, the cells were treated for 2 days with a hormone mixture of 10 g/mL insulin, 1 M dexamethasone, and 0.5 mM 3-isobutyl-1-methylxanthine in a standard medium to induce the differentiation into adipocytes. The medium was then replaced with complete medium, which contained 5 g/mL insulin in standard medium, and was changed every 2 days. Five days later, the medium was replaced with serum-deprived medium (FBS-free DMEM supplemented with 5 g/mL insulin), and the cells were incubated for 24 h. The plates were then replenished with 2 mL serum-deprived medium containing BPA at the indicated concentrations, and the cells were incubated for 24 h, harvested in 0.6 mL lysis buffer [15 mM Tris, 1% Nonidet P-40, 150 mM NaCl, 1 mM EDTA, protease inhibitor cocktail (1:100), pH 7.5], sonicated briefly at 0 , and centrifuged. Aliquots of the infranatant were used for measurements of adiponectin, leptin, DNA, and protein and for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The medium was filtered through a 0.2 m filter and used for adi-ponectin measurement. The amounts of adiponectin and leptin were measured using an adiponectin ELISA kit and a leptin ELISA kit, respectively, according to the manufacturer's instructions. DNA was measured fluorometrically by the method of Hinegardner 27) . Protein was measured using a DC protein assay kit according to the manufacturer's instructions.
In another series of experiments, we used two antagonists: a peroxisome proliferator-activated receptor (PPAR ) antagonist GW9662 and an estrogen receptor (ER) antagonist ICI 182,780. Following the hormonal induction of differentiation, 3T3-L1 cells were cultured for 5 days in complete medium. The plates were replenished with serum-deprived medium. Twenty-four hours later, the medium was changed to serum-deprived medium containing 1 M antagonist, and the cells were incubated for 1 h. The plates were replenished with 2 mL serum-deprived medium containing either 1 M of the antagonist alone or a combination of 80 M BPA and 1 M antagonist. Twenty-four hours later, the cells were harvested to measure adiponectin and DNA as described above.
Western Blotting for Akt, p-Akt, Adiponectin and -Actin
The proteins (5 g protein/lane) in the infranatant of cell homogenate were separated by SDS-PAGE using either a 7.5% resolving gel for Akt and p-Akt or a 10% resolving gel for adiponectin and -actin. Proteins were transferred electrophoretically to Hybond-P membranes. The blotted membranes were incubated for 1 h with a primary antibody (1:1,000 dilution), and then incubated for 1 h with a horseradish peroxidase-conjugated secondary antibody (1:25,000 dilution). The blots were visualized with the ECL Advance Western blotting detection kit according to the manufacturer's instructions. The membrane was exposed for 1 − 2 min to Hyperfilm ECL with an intensifying screen. Relative densitometric units were determined using analysis software, Diversity Database TM (v. 1.1; Toyobo Co., Ltd., Osaka, Japan).
Statistical Analyses
Significant differences among 3 − 5 independent groups were statistically evaluated using one-way ANOVA, and subsequent comparisons were performed using the Tukey-Kramer test. Significant differences between 2 independent groups were analyzed using Student's t-test. Pearson's r was used to calculate the correlation between the amounts of intracellular adiponectin and adiponectin in the medium. For all statistical analyses, the criterion for significance was p 0.05. All values are expressed as the means SD.
Results
Does BPA Affect Adiponectin Production and Secretion in 3T3-L1 Adipocytes ?
3T3-L1 adipocytes were treated for 24 h with increasing doses of BPA in serum-deprived medium, which contains 5 g/mL insulin in FBS-free DMEM. The control cultures (i.e., BPA was absent during a 24 h-treatment period) contained 49.4 g/mg DNA of adiponectin in the cells and secreted 35.5 g/mg DNA of adiponectin into the medium. The presence of BPA caused dose-dependent decreases in both the amounts of intracellular adiponectin (Fig. 1A) and adiponectin in the medium (Fig. 1B) . BPA at 80 M decreased the amount of intracellular adiponectin by 60% ( p 0.01) and the amount of adiponectin by 56% ( p 0.01) in the medium. BPA at up to 80 M did not cause any changes in the DNA content of the cultures (Fig. 1C) . Cells on the bottom of the plates in both the control and BPA-treated cultures excluded trypan blue (data not shown). The results of DNA measurement and trypan blue exclusion test indicate that BPA at up to 80 M is non-toxic to 3T3-L1 adipocytes. Based on these findings, we conclude that BPA inhibits adiponectin production and secretion, and that this BPA-induced inhibition is not due to a cytotoxic effect.
When the data shown in Fig. 1A and 1B were analyzed together, a strong positive correlation between the amounts of intracellular adiponectin and adiponectin in the medium was observed (r 0.904, p 0.0001) (Fig. 1D) .
Association of Akt Signaling with Adiponectin Production 3T3-L1 adipocytes were treated for 24 h with or without 80 M BPA and the expression of Akt, p-Akt, adiponectin, and -actin was analyzed by Western blot (Fig. 2A) . BPA decreased the levels of Akt and p-Akt by 46% ( p 0.01) (Fig. 2B) and 29% ( p 0.01) (Fig. 2C) , respectively. Similar to the results of the adiponectin measurements, BPA decreased the level of adiponectin by 51% ( p 0.05) (Fig. 2D ). There were no differences in the levels of -actin between the control and BPA-treated cultures (Fig. 2E) .
Effects of GW9662 and ICI 182,780 on BPAinduced Decrease in Adiponectin Production
To evaluate whether BPA acts through either PPAR or ER, the experiments were performed either using a PPAR antagonist GW9662 or an ER antagonist ICI 182,780. 3T3-L1 adipocytes were treated for 24 h with or without 80 M BPA in the absence or presence of 1 M antagonist. The amount of intracellular adiponectin in cultures treated with either a combination of BPA and GW9662 (Fig. 3A) or a combination of BPA and ICI 182,780 (Fig. 3B) was identical to that in cultures treated with BPA alone. The amount of intracellular adiponectin in cultures treated with either GW9662 alone or ICI 182,780 alone was identical to that in control cultures, indicating that both antagonists alone did not affect adiponectin production.
Effects of Bisphenols with Different Substituents on Adiponectin Production and Secretion
BPF, BPE, BPA, and BPB are chemicals with different lengths of alkyl substituents at the central carbon atom. The order of length was BPB BPA BPE BPF (Fig. 4) . 3T3-L1 adipocytes were treated for 24 h with or without 80 M chemical, and the amounts of intracellular adiponectin (Fig. 5A) and adiponectin in the medium (Fig. 5B) were measured: 24% ( p 0.01) and 18% ( p 0.05), respectively, smaller in BPF-treated cultures; 38% ( p 0.01) and 46% ( p 0.01), respectively, smaller in BPE-treated cultures; 57% ( p 0.01) and 58% ( p 0.01), respectively, smaller in BPAtreated cultures; and 89% (p 0.01) and 43% (p 0.01), respectively, smaller in BPB-treated cultures than in control cultures. The chemicals tested did not cause any changes in the DNA content of the cultures (legend in Fig. 5) .
Next, we examined the effects of chemicals with . 6 ). BABCF, BADA, and BADM are ester derivatives of BPA (Fig. 4) . In BABCF-treated cultures, the amounts of intracellular adiponectin and adiponectin in the medium were 62% ( p 0.01) (Fig. 6A) and 41% ( p 0.01) (Fig. 6B) , respectively, smaller than in control cultures. These amounts in BABCF-treated cultures were similar to those in BPA-treated cultures. In BADA-treated cultures, the amount of intracellular adiponectin was 28% smaller ( p 0.01), but the amount of adiponectin in the medium was 35% larger ( p 0.01) than in control cultures. In BADM-treated cultures, the amount of intracellular adiponectin was similar to that in control cultures, and the amount of adiponectin in the medium was 56% larger ( p 0.01) than in control cultures. BADGE and BADAA are ether derivatives of BPA (Fig. 4) , and neither caused any changes in the amount of intracellular adiponectin (Fig. 6C) . The amount of adiponectin in the medium of BADGEtreated cultures was 75% larger ( p 0.01) than in control cultures (Fig. 6D) . The amount of adiponectin in the medium of BADAA-treated cultures did not differ significantly from that of control cultures. 
Discussion
In the present study, we showed that BPA dosedependently decreased the amounts of intracellular adiponectin (Fig. 1A) and adiponectin in the medium (Fig. 1B) of cultures of 3T3-L1 adipocytes. As shown in Fig. 1D , the BPA-induced decrease in the amount of intracellular adiponectin was associated with the BPA-induced decrease in the amount of adiponectin in the medium. These findings indicate that BPA inhibits adiponectin production in cells, resulting in reduced secretion of adiponectin. Similar to BPA, bisphenols with different lengths of alkyl substituents at the central carbon atom also inhibited adiponectin production (Fig. 5A) and secretion (Fig. 5B) . The order of potential to inhibit adiponectin production was BPB BPA BPE BPF, consistent with the order of the length of alkyl groups at the central carbon atom (Fig. 4) ; namely, the longer the alkyl groups at the central carbon atom, the stronger the potential to inhibit adiponectin production. These findings suggest that lower polarity at the central carbon atom may enhance the potential to inhibit adiponectin production. Perez et al. 28) reported that in cultures of MCF-7 cells, the length of the alkyl groups at the central carbon atom of bisphenols is associated with the estrogenic potency estimated from relative cell proliferation activity.
Microgram amounts of BPA (4 − 23 g/can) are found in both extracted foods and water from autoclaved cans 5) . These amounts of BPA are close to those used in this study. Olea et al. 6) detected 90 − 931 g BPA in the saliva during the first 1 h after the application of dental sealant (50 mg). The maximum daily intake of BPA by humans is reported to range from 0.050 to 0.905 g/kg body weight/day 29) . The concentrations of BPA in human serum and breast milk are very low. Takeuchi et al. 9) reported that the concentrations of BPA in human serum are 0.71 0.09 ng/mL in young non-obese women and 1.04 0.09 ng/mL in young obese women ( p 0.05, vs young non-obese women). The concentration of BPA in human breast milk is 0.61 0.2 ng/mL 4) . These concentrations of BPA are close to those (0.1 − 100 nM) used by Ben-Jonathan's group 30, 31) . They reported that BPA at lower doses (0.1 and 1 nM) decreased adiponectin secretion from human adipose tissue explants and adipocytes; however, they did not determine the mechanism by which BPA decreases adiponectin secretion.
The PI3K-Akt signaling pathway, activated when insulin binds to its cell-surface receptor, plays a pivotal A B C D role in the regulation of gene expression and secretion of adiponectin 23, 32) . Inhibition of PI3K-Akt signaling by either the expression of a dominant-negative form of Akt in 3T3-L1 adipocytes or the treatment of 3T3-L1 adipocytes with wortmannin, which is a potent inhibitor of PI3K, decreases insulin-stimulated secretion of adiponectin 23) . Therefore, using Western blot analysis, we examined the levels of Akt and p-Akt in the control cultures (i.e., insulin alone during a 24-h treatment period) and BPA-treated cultures (i.e., insulin and BPA during the same period) to explore whether BPA affects the PI3K-Akt signaling pathway. The levels of Akt (Fig. 2B) and p-Akt (Fig. 2C) in BPA-treated cultures were significantly lower than those in control cultures, thus indicating that BPA inhibits the expression and phosphorylation of Akt. The level of adiponectin also was significantly lower in BPA-treated cultures than in control cultures (Fig. 2D) . These findings suggest that BPA may downregulate Akt signaling, resulting in reduced production of adiponectin.
BPA accumulates in the brown and white adipose tissues in rats 33) . BADGE is isolated from nuclear extracts of 3T3-L1 and 3T3-F442A adipocytes cultured in plastic culture dishes 34) . Thus, these chemicals appear to penetrate adipocytes. This raises the question as to what kind of receptor is involved in the actions of BPA in 3T3-L1 adipocytes. PPAR is a nuclear hormone receptor expressed at extremely high levels in adipose tissue and is a major coordinator of adipocyte gene expression 35) . TZDs are synthetic PPAR agonists and increase the mRNA expression and secretion of adiponectin in 3T3-L1 adipocytes 24, 25) . Moreover, administration of TZDs to mice increases plasma adiponectin levels and the expression of adiponectin mRNA in adipose tissue 25) . Neschen et al. 36) reported that administration of fish oil to mice increases plasma adiponectin levels and that BADGE, which binds to PPAR and antagonizes the actions of PPAR agonists 34) , blocks the fish oil-induced increase in adiponectin. They concluded that fish oil increases adiponectin secretion by a PPAR -dependent mechanism in mice; therefore, to explore the involvement of PPAR in BPA-induced inhibition of adiponectin production, experiments were performed using a PPAR antagonist, GW9662. As shown in Fig. 3A , GW9662 did not block the BPA-induced decrease in the amount of intracellular adiponectin. Based on this finding, we conclude that BPA inhibits adiponectin production via an alternative mechanism that does not involve PPAR in 3T3-L1 adipocytes. This conclusion may be supported by the finding of Wright et al. 34) that BPA does not bind to PPAR .
BPA mimics the actions of estrogens through the classical nuclear ER. BPA, although less potent than -estradiol (E2), increases heat shock protein (hsp90 ) in the uteri of mice, and ICI 182,780 attenuates BPAand E2-induced increases in uterine hps90 levels 37) . Similar to E2, BPA promotes the growth of several types of cancer cells, and ICI 182,780 effectively abolishes the promoting effect 38, 39) . As shown in Fig. 3B , however, ICI 182,780 cannot reverse the inhibitory effect of BPA on adiponectin production, thus indicating that BPA does not act through the classical nuclear ER in 3T3-L1 adipocytes. Previously, we found that 4-nonylphenol, which is another kind of estrogenic endocrine-disrupting chemical found in water and fish from rivers in Japan 40) , decreases TG accumulation and lipoprotein lipase activity in fully differentiated 3T3-L1 cells; however, ICI 182,780 does not reverse these decreasing effects 14) . Thus, it seems that the classical nuclear ER is not involved in the actions of estrogenic endocrine-disrupting chemicals in 3T3-L1 adipocytes.
In the present study, we could not identify the receptor involved in the BPA-induced inhibition of adiponectin production in 3T3-L1 adipocytes. Several lines of evidence reveal that BPA binds to receptors other than classical nuclear ERs. BPA strongly binds to human estrogen-related receptor (ERR ), an orphan receptor and one of the nuclear receptors 41) . Kubo et al. 42) found that gene knockdown by ERR -specific small interfering RNA (siRNA) results in mRNA downregulation of adipogenic marker genes, including PPAR and fatty acid binding protein 4, in 3T3-L1 preadipocytes and mesenchymal ST2 and C3H10T1/2 cells in adipogenesis medium. They mentioned that ERR positively regulates adipocyte differentiation by modulating the expression of various adipogenesis-related genes. Bouskine et al. 43) reported that BPA promotes human seminoma cell proliferation via a G-protein-coupled nonclassical membrane ER. Hugo et al. 30) reported that ERR and G-protein-coupled receptor 30 (GPR30) are expressed in human adipose tissue; however, they did not determine whether these receptors are involved in the BPAinduced inhibition of adiponectin secretion. Hence, further studies using siRNA are needed to identify the receptor involved in the actions of BPA in adipocytes.
BABCF also inhibited adiponectin production ( Fig. 6A) and secretion (Fig. 6B) . The potential of BABCF-treated cultures to inhibit adiponectin production and secretion was similar to that of BPA-treated cultures, indicating that free hydroxyl groups in the para position of the phenolic rings were not necessarily needed to inhibit adiponectin production and se-cretion. Taken together, five of the 9 bisphenols tested possessed the ability to inhibit both the production and secretion of adiponectin. Since adiponectin is an important modulator of insulin sensitivity [18] [19] [20] , prolonged exposure to the above-mentioned bisphenols may enhance insulin resistance and promote the development of diabetes, obesity, and atherosclerosis. We previously found that oral administration of BPA (in drinking water) during the perinatal and postnatal periods caused the development of hyperlipidemia and increases in body weight and adipose tissue mass in mice on postnatal day 31 compared with age-matched control mice 15) . Others have also reported that perinatal exposure to BPA increases body weight in mice 44) and rats 45) . In contrast to BPA, two chemicals (BADGE and BADA) stimulated adiponectin secretion without affecting adiponectin production (Fig. 6) . Yun et al. 46) reported that treatment of high fat diet-fed mice with BADGE increases the amount of adiponectin in adipose tissue. Both our findings and theirs suggest that BADGE may possess agonistic activity in adiponectin production and secretion. Others have also reported that BADGE acts as a PPAR agonist in two different cell lines 47, 48) . Bishop-Bailey et al. 47) reported that, like a TZD ciglitizone, BADGE induces cell death in a human umbilical vein endothelial cell line, ECV304. Nakamura et al. 48) reported that, like a TZD pioglitazone, BADGE suppresses lipopolysaccharide-induced tumor necrosis factor-production in a murine macrophage-like cell line, RAW 264.7.
Conclusion
We demonstrated for the first time that BPA downregulates Akt signaling and inhibits adiponectin production. In addition, five of the 9 bisphenols tested inhibited adiponectin production and secretion. These data provide evidence supporting that BPA and some BPA-related chemicals are hazardous to human health.
